热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　腾盛博药-B（02137）盘中涨超8%，截至发稿，股价上涨4.63%，现报2.26港元，成交额2533.92万港元。

　　国金证券发布研报称，腾盛博药专注于感染性疾病和中枢神经系统疾病领域，推进着涵盖多种独特候选药物的产品管线。该行指出，近期围绕Elebsiran，腾盛博药将达成多项里程碑：25年上半年，ENSURE研究第4队列：48周治疗结束数据已在EASL2025上公布；ENSURE研究第1-3队列：24周随访数据已在EASL2025上公布；ENSURE研究第4队列：24周随访数据；ENRICH研究：治疗结束数据。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.